title: Intensive LDL lowering therapy for prevention of recurrent cardiovascular events: a word of caution.
authors.affiliation: Department of Cardiology, Thoraxcenter, Erasmus University Medical Center, Room Ba 593, 's Gravensijkwal 230, PO box 2040, Rotterdam 3000 CA, The Netherlands msimoons@xs4all.nl.
authors.forename: Maarten L
authors.initials: ML
authors.lastname: Simoons
authors.affiliation: Department of Cardiology, Thoraxcenter, Erasmus University Medical Center, Room Ba 593, 's Gravensijkwal 230, PO box 2040, Rotterdam 3000 CA, The Netherlands.
authors.forename: Jaap W
authors.initials: JW
authors.lastname: Deckers
mesh_terms: D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D008078:Cholesterol, LDL / Q000187:drug effects; D004359:Drug Therapy, Combination; D000069438:Ezetimibe / Q000627:therapeutic use; D006801:Humans; D006937:Hypercholesterolemia / Q000517:prevention & control*; D000091362:PCSK9 Inhibitors; D055502:Secondary Prevention / Q000379:methods; D019821:Simvastatin / Q000627:therapeutic use; D016896:Treatment Outcome; D000071449:Proprotein Convertase 9
chemical_list: D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D000069438:Ezetimibe; D000091362:PCSK9 Inhibitors; D019821:Simvastatin; C472125:PCSK9 protein, human; D000071449:Proprotein Convertase 9